Cost Effective and Secure Archive Management Solution
First introduced in 2003, CellNass is an innovative archive management service delivered by CellPath Ltd, aimed at the needs of those within Cellular Pathology.
The majority of NHS hospitals in the UK are now using CellNass. This has made us the market-leader for Cellular Pathology archive management and the go-to company for those seeking to transfer materials to an off-site secure facility.
In our last Your Space issue, we told you about our exciting plans to develop a fourth archiving facility. With the building having commenced, we would like to take you for a virtual look inside the warehouse so we can tell you a little more about the innovations we will use to manage the archive.
Paul Webber tells us more: “Having now broken ground on the project using local contractors, I can talk to you a bit more about Autostore, a state-of-the-art robotic storage system which will be fitted inside the new building. Autostore provides high-density storage giving us more capacity and is hyper-secure because you can’t access it without a robot. It is efficient for picking and can preload recalled specimens onto the picking system. This means if we know what recalls are coming along it will line them up and pick them up automatically with an operator supervising. The eventual vision is that this hardware can be linked into the CellTrak software so when a customer is recalling material from the Autostore matrix then the robot can start picking and preparing it. This will save us having to go to the material and instead will see the material brought to us. The current process can be quite intensive in terms of labour and logistics and collecting material, this new system would mean we will be working more efficiently. The Autostore system is modular so it is very flexible and adaptable to whatever space we have. We can even choose to fit one portion of the warehouse with the system, to begin with, and then expand our installation as more material is collected. We have worked out that when the warehouse is completely fitted out with Autostore we can archive over 130 million additional blocks on top of our existing capacity. Most importantly, the new system will integrate well with the CellNass team. In the same building, we will also be having a new staff canteen for our whole workforce as well as additional office space. Once again, we would like to thank our customers for their continued support, and we look forward to inviting you to visit us!”
Announcement – CellNass Response to the Current Coronavirus Situation
At the time of writing, the number of cases and risk of exposure in the UK is gaining speed, and CellPath is taking necessary precautions to ensure we are best prepared and protected as the situation develops.
We have taken the difficult decision to cease material uplifts until further notice. We hope you can understand the reasons behind us taking this decision but believe it to be the responsible thing to do to help ensure the safety of both our staff, their families and our customers and their families.
At the current time, there are no changes to this service. Recall logistics are done through TNT, and should they advise us about service disruptions, we will, of course, keep you updated.
The company has also introduced several company-wide initiatives in response to government advice.
This week, we have introduced remote working for our staff where possible and issued advice to staff recommending compliance with the most up-to-date government information, beginning with frequent hand washing and containing coughs or sneezes
We have manufactured our own ‘Alcoholic Hand Sanitiser’ to the World Health Organisation formula and issued to operational staff onsite.
We are also asking staff to advise us of their personal overseas travel plans to ensure they follow the most recent advice for the country they return from. This includes the company advising self-isolation as appropriate.
Business travel within the UK will be subject to tighter restrictions with staff requested to use digital conferencing facilities instead of face-to-face meetings whenever possible. Hospitals which we need to visit to conduct CellNass operations will be sent a questionnaire to allow us to identify the risk posed by the visit. At this time, we will also be minimising the number of invitations we extend to visitors to CellPath.
All overseas travel is cancelled until further notice with all members of staff back home.
CellPath would like to remind customers that we are a British-based manufacturer, sourcing the majority of components from within the United Kingdom (UK). We have extended our operational manufacturing hours to ensure our stock levels of key product lines are high. Where we source the few components from outside the UK, recent investment in new warehousing facilities has allowed us to implement a plan to increase stock holdings. We hope that this will ensure the continuous and timely supply of products to our customers.
We thank you for your patience and cooperation as we endeavour to protect our workforce, customers and their respective wider families. We will continue to monitor developments and government advice and will issue further updates if our circumstances change.